New York University Skip to Content Skip to Search Skip to Navigation Skip to Sub Navigation

NYU College of Dentistry’s Dr. Daniel Malamud and UMDNJ Share $3.2 Million NIH Grant for HIV Prevention Research

August 15, 2011
N-467, 2010-11

The National Institute of Allergy & Infectious Diseases, part of the National Institutes of Health, has awarded a joint, five-year, $3.2 million grant to the New York University College of Dentistry and the University of Medicine and Dentistry of New Jersey to conduct the first study to evaluate whether gp340, a protein found in saliva and other mucosal secretions, can prevent HIV transmission in vivo.  

The study is being led by Dr. Daniel Malamud, professor of basic science and craniofacial biology and director of the HIV/AIDS Research Program at the NYU College of Dentistry, and Dr. Min Lu, professor of microbiology and molecular genetics at the Public Health Research Institute Center and at the UMDNJ New Jersey Medical School. Dr. Malamud will generate the gp340 molecules and smaller fragments of the molecule for laboratory analysis, and Dr. Lu will analyze the biophysical interactions of these proteins with HIV.

Dr. Malamud’s research on the antiviral activity of gp340 and other human salivary proteins has been funded by the NIH for over 25 years. Although it has been established that salivary proteins can protect against the HIV virus, the mechanisms by which the proteins offer protection are not fully understood.

Gp340 was shown to inhibit HIV transmission in earlier in vitro research. Dr. Malamud and Dr. Lu will evaluate gp340 antiviral activity in immune deficient mice that have had their immune systems reconstituted with human immune cells – an experimental model developed by Dr. Victor Garcia Martinez, professor of medicine at the University of North Carolina School of Medicine and a co-investigator on the study.

The researchers will inject the mice’s salivary glands with a vector carrying a gene that produces the portion of gp340 that has been identified as inhibiting HIV infection. Once the mice have secreted the gp340 fragments in their saliva, the investigators will inject HIV into the oral cavity. They will compare these mice with a second group that have been injected with HIV but not gp340 to determine whether gp340 protected the first group from infection.

The study will also analyze the impact of gp340 on HIV transmission in the mouse female reproductive tract. Previous in vitro research has suggested that gp340 on the surface of cells in the reproductive tract may enhance HIV infection by binding HIV to vaginal cells. The researchers plan to assess whether introducing soluble gp340 into the female reproductive tract would override the binding of surface cells to HIV and reduce HIV infection.

Findings from the study could help in the development of new antiviral drugs to protect against HIV.

In addition to Dr. Garcia Martinez, co-investigators on the study include Dr. William Abrams, research professor in basic science and craniofacial biology, and Ms. Cheryl Barber, a research scientist in basic science and craniofacial biology, both at the NYU College of Dentistry.

About New York University College of Dentistry Founded in 1865, New York University College of Dentistry (NYUCD) is the third oldest and the largest dental school in the US, educating more than 8 percent of all dentists. NYUCD has a significant global reach and provides a level of national and international diversity among its students that is unmatched by any other dental school.

 

This Press Release is in the following Topics:
NYUToday-feature, Research News, College of Dentistry

Type: Press Release

Press Contact: Christopher James | (212) 998-6876

NYU College of Dentistry’s Dr. Daniel Malamud and UMDNJ Share $3.2 Million NIH Grant for HIV Prevention Research

Dr. Daniel Malamud


Search News



NYU In the News

CUSP Unveils its “Urban Observatory”

Crain’s New York Business profiled CUSP’s “Urban Observatory” that is continuously photographing lower Manhattan to gather scientific data.

Post-Sandy Upgrades at the Langone Medical Center

NY1 reported on the major post-Sandy upgrades and renovations made at the Medical Center to protect the hospital from future catastrophic storms.

Steinhardt Research Helps Solve Tough Speech Problems.

The Wall Street Journal reported on research at Steinhardt’s Department of Communicative Sciences and Disorders, including an interview with Assistant Professor Tara McAllister Byun, that uses ultrasound to help solve tough speech problems.

Times Column Lauds Professor Stevenson’s New Memoir

New York Times columnist Nicholas Kristof wrote a column about “Just Mercy,” a new memoir by Law Professor Bryan Stevenson, the founder of the Equal Justice Initiative, whom he noted has been called America’s Nelson Mandela.

Entrepreneurship Lab Opens at NYU

Crain’s New York Business covered the opening of the Mark and Debra Leslie Entrepreneurial eLab, which will be the headquarters for NYU’s Entrepreneurial Institute and all of the University’s programs aimed at promoting innovation and startups.

NYU Footer